Newsfeeds Archive - Spark Newswire

1 minute read

June 18, 8:23 AM

Orsini Specialty Pharmacy (Orsini), and Zevra Therapeutics, Inc. (NASDAQ:ZVRA) (Zevra) today announced that Orsini is now the pharmacy partner for OLPRUVA® (sodium phenylbutyrate) for oral suspension. OLPRUVA®

ZVRA

1 minute read

Earnings

Zevra Therapeutics: Q4 Earnings Insights

By Benzinga Insights

March 28, 5:05 PM

Zevra Therapeutics (NASDAQ:ZVRA) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:32 PM. Here’s what…

ZVRA

5 minute read

Earnings

Earnings Scheduled For March 28, 2024

By Benzinga Insights

March 28, 5:24 AM

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.

ACHV

1 minute read

Earnings

Earnings Outlook For Zevra Therapeutics

By Benzinga Insights

March 27, 12:02 PM

Zevra Therapeutics (NASDAQ:ZVRA) is set to give its latest quarterly earnings report on Thursday, 2024-03-28. Here’s what investors…

ZVRA

2 minute read

Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday

By Avi Kapoor

December 28, 9:35 AM

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

BALL

25 minute read

Earnings

Earnings Scheduled For November 7, 2023

By Benzinga Insights

November 7, 7:34 AM

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

ABUS

1 minute read

Earnings

Zevra Therapeutics’s Earnings: A Preview

By Benzinga Insights

November 6, 4:01 PM

Zevra Therapeutics (NASDAQ:ZVRA) is set to give its latest quarterly earnings report on Tuesday, 2023-11-07. Here’s what investors…

ZVRA

1 minute read

Events
News

Zevra Therapeutics Announced Late Saturday, Presentation Of Full Data Set On The Cardiovascular Safety And Pharmacokinetics Of SDX, The Sole API In KP1077, In Healthy Volunteers At Psych Congress 2023

By Charles Gross

September 10, 10:38 AM

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced a poster presentation featuring study data that underscores the cardiovascular safety profile of

ZVRA